HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High phosphoantigen levels in bisphosphonate-treated human breast tumors promote Vgamma9Vdelta2 T-cell chemotaxis and cytotoxicity in vivo.

Abstract
The nitrogen-containing bisphosphonate zoledronic acid (ZOL), a potent inhibitor of farnesyl pyrophosphate synthase, blocks the mevalonate pathway, leading to intracellular accumulation of isopentenyl pyrophosphate/triphosphoric acid I-adenosin-5'-yl ester 3-(3-methylbut-3-enyl) ester (IPP/ApppI) mevalonate metabolites. IPP/ApppI accumulation in ZOL-treated cancer cells may be recognized by Vγ9Vδ2 T cells as tumor phosphoantigens in vitro. However, the significance of these findings in vivo remains largely unknown. In this study, we investigated the correlation between the anticancer activities of Vγ9Vδ2 T cells and the intracellular IPP/ApppI levels in ZOL-treated breast cancer cells in vitro and in vivo. We found marked differences in IPP/ApppI production among different human breast cancer cell lines post-ZOL treatment. Coculture with purified human Vγ9Vδ2 T cells led to IPP/ApppI-dependent near-complete killing of ZOL-treated breast cancer cells. In ZOL-treated mice bearing subcutaneous breast cancer xenografts, Vγ9Vδ2 T cells infiltrated and inhibited growth of tumors that produced high IPP/ApppI levels, but not those expressing low IPP/ApppI levels. Moreover, IPP/ApppI not only accumulated in cancer cells but it was also secreted, promoting Vγ9Vδ2 T-cell chemotaxis to the tumor. Without Vγ9Vδ2 T-cell expansion, ZOL did not inhibit tumor growth. These findings suggest that cancers-producing high IPP/ApppI levels after ZOL treatment are most likely to benefit from Vγ9Vδ2 T-cell-mediated immunotherapy.
AuthorsIsmahène Benzaïd, Hannu Mönkkönen, Verena Stresing, Edith Bonnelye, Jonathan Green, Jukka Mönkkönen, Jean-Louis Touraine, Philippe Clézardin
JournalCancer research (Cancer Res) Vol. 71 Issue 13 Pg. 4562-72 (Jul 01 2011) ISSN: 1538-7445 [Electronic] United States
PMID21646473 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2011 AACR.
Chemical References
  • Antigens, Neoplasm
  • Diphosphonates
  • Hemiterpenes
  • Imidazoles
  • Organophosphorus Compounds
  • Receptors, Antigen, T-Cell, gamma-delta
  • triphosphoric acid 1-adenosin-5'-yl ester 3-(3-methylbut-3-enyl) ester
  • isopentenyl pyrophosphate
  • Zoledronic Acid
  • Adenosine Triphosphate
Topics
  • Adenosine Triphosphate (analogs & derivatives, metabolism)
  • Animals
  • Antigens, Neoplasm (immunology, metabolism)
  • Breast Neoplasms (drug therapy, immunology, metabolism)
  • Cell Line, Tumor
  • Cytotoxicity, Immunologic
  • Diphosphonates (pharmacology)
  • Female
  • Hemiterpenes (metabolism)
  • Humans
  • Imidazoles (pharmacology)
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • Organophosphorus Compounds (metabolism)
  • Phosphorylation
  • Receptors, Antigen, T-Cell, gamma-delta (immunology)
  • T-Lymphocytes (drug effects, immunology)
  • Zoledronic Acid

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: